Cargando…
Cervicovaginal Safety of the Formulated, Biguanide-Based Human Immunodeficiency Virus Type 1 (HIV-1) Inhibitor NB325 in a Murine Model
Vaginal microbicides that reduce or eliminate the risk of HIV-1 sexual transmission must do so safely without adversely affecting the integrity of the cervicovaginal epithelium. The present studies were performed to assess the safety of the biguanide-based antiviral compound NB325 in a formulation s...
Autores principales: | Lozenski, Karissa, Kish-Catalone, Tina, Pirrone, Vanessa, Rando, Robert F., Labib, Mohamed, Wigdahl, Brian, Krebs, Fred C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202145/ https://www.ncbi.nlm.nih.gov/pubmed/22131821 http://dx.doi.org/10.1155/2011/941061 |
Ejemplares similares
-
Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety
por: Lozenski, Karissa, et al.
Publicado: (2012) -
A Styrene-alt-Maleic Acid Copolymer Is an Effective Inhibitor of R5 and X4 Human Immunodeficiency Virus Type 1 Infection
por: Pirrone, Vanessa, et al.
Publicado: (2010) -
Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1
por: Pirrone, Vanessa, et al.
Publicado: (2012) -
Contact allergy to polyhexamethylene biguanide (polyaminopropyl biguanide)
por: Sukakul, Thanisorn, et al.
Publicado: (2020) -
cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells
por: Banerjee, Anupam, et al.
Publicado: (2017)